Parenchyma-sparing pancreatectomy for presumed noninvasive intraductal papillary mucinous neoplasms of the pancreas

Annals of Surgery

Volumn 260, Issue 2, 2014, Pages 364-371

  Sauvanet, Alain ^a,b,c   Gaujoux, Sébastien ^a,b,c   Blanc, Benjamin ^a   Couvelard, Anne ^a,b,c   Dokmak, Safi ^a,c   Vullierme, Marie Pierre ^a,c   Ruszniewski, Philippe ^a,b,c   Belghiti, Jacques ^a,b,c   Lévy, Philippe ^a,b,c  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Department Hospitalo Universitaire UNITY   (France)

Author keywords

Central pancreatectomy; Enucleation; Intraductal papillary mucinous neoplasms; Parenchyma sparing pancreatectomy; Resection of uncinate process

Indexed keywords

ENZYME; INSULIN; ORAL ANTIDIABETIC AGENT; CONTRAST MEDIUM; TUMOR MARKER;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTADENOMA; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; DYSPLASIA; ENDOSCOPIC ECHOGRAPHY; EPIGASTRIC PAIN; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FROZEN SECTION; HOSPITAL READMISSION; HUMAN; INSULIN TREATMENT; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INTRAOPERATIVE PERIOD; INVASIVE CARCINOMA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PANCREAS; PANCREAS CYST; PANCREAS DUCT; PANCREAS FISTULA; PANCREAS INSUFFICIENCY; PANCREAS PARENCHYMA; PANCREAS PSEUDOCYST; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PANCREATITIS; PATIENT SELECTION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REOPERATION; RISK FACTOR; SUPPLEMENTATION; SURGICAL MORTALITY; TUMOR RECURRENCE; ADENOCARCINOMA, MUCINOUS; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA, MUCINOUS; AGED; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84905594556     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000601     Document Type: Article

References (59)

1. Gaujoux S, Brennan MF, Gonen M, et al. Cystic lesions of the pancreas: changes in the presentation and management of 1, 424 patients at a single institution over a 15-year time period. J Am Coll Surg. 2011;212:590-600; discussion 600-603.
2. D'Angelica M, Brennan MF, Suriawinata AA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg. 2004;239:400-408.
3. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788-797; discussion 797-799.
4. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007;246:644-651; discussion 651-654.
5. Schnelldorfer T, Sarr MG, Nagorney DM, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008;143:639-646; discussion 646.
6. Yang AD, Melstrom LG, Bentrem DJ, et al. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007;142:529-534; discussion 534-537.
7. Gaujoux S, Sauvanet A, Vullierme MP, et al. Ischemic complications after pancreaticoduodenectomy: incidence, prevention, and management. Ann Surg. 2009;249:111-117.
8. Cameron JL, Riall TS, Coleman J, et al. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244:10-15.
9. House MG, Fong Y, Arnaoutakis DJ, et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg. 2008;12:270-278.
10. Lemaire E, O'Toole D, Sauvanet A, et al. Functional and morphological changes in the pancreatic remnant following pancreaticoduodenectomy with pancreaticogastric anastomosis. Br J Surg. 2000;87:434-438.
11. Ishikawa O, Ohigashi H, Eguchi H, et al. Long-term follow-up of glucose tolerance function after pancreaticoduodenectomy: comparison between pancreaticogastrostomy and pancreaticojejunostomy. Surgery. 2004;136:617-623.
12. Falconi M, MantovaniW, Crippa S, et al. Pancreatic insufficiency after different resections for benign tumours. Br J Surg. 2008;95:85-91.
13. King JC, Hines OJ. Predicting exocrine insufficiency following pancreatic resection. J Surg Res. 2010;164:e43-e45.
14. Cherif R, Gaujoux S, Couvelard A, et al. Parenchyma-sparing resections for pancreatic neuroendocrine tumors. J Gastrointest Surg. 2012;16:2045-2055.
15. Salvia R, Crippa S, Falconi M, et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut. 2007;56:1086-1090.
16. Tanno S, Nakano Y, Nishikawa T, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut. 2008;57:339-343.
17. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
18. Yamaguchi K, Shimizu S, Yokohata K, et al. Ductal branch-oriented minimal pancreatectomy: two cases of successful treatment. J Hepatobiliary Pancreat Surg. 1999;6:69-73.
19. Paik KY, Choi SH. Experience of limited pancreatic head resection for management of branch duct intraductal papillary mucinous neoplasm in a single center. World J Gastroenterol. 2009;15:2904-2907.
20. Nakagohri T, KonishiM, Inoue K, et al. Inferior head resection of the pancreas and cyst resection for choledochal cyst with chronic calcifying pancreatitis. Hepatogastroenterology. 2004;51:1504-1505.
21. Adham M, Giunippero A, Hervieu V, et al. Central pancreatectomy: singlecenter experience of 50 cases. Arch Surg. 2008;143:175-180; discussion 180-181.
22. Sauvanet A, Partensky C, Sastre B, et al. Medial pancreatectomy: a multiinstitutional retrospective study of 53 patients by the French Pancreas Club. Surgery. 2002;132:836-843.
23. Crippa S, Bassi C, Warshaw AL, et al. Middle pancreatectomy: indications, short- and long-term operative outcomes. Ann Surg. 2007;246:69-76.
24. Sharma MS, Brams DM, Birkett DH, et al. Uncinatectomy: a novel surgical option for the management of intraductal papillary mucinous tumors of the pancreas. Dig Surg. 2006;23:121-124.
25. Hwang HK, Park JS, Kim JK, et al. Comparison of efficacy of enucleation and pancreaticoduodenectomy for small (<3 cm) branch duct type intraductal papillary mucinous neoplasm located at the head of pancreas and the uncinate process. Yonsei Med J. 2012;53:106-110.
26. Nakagohri T, Kinoshita T, KonishiM, et al. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms. J Hepatobiliary Pancreat Sci. 2010;17:798-802.
27. Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183-197.
28. Kawai M, Uchiyama K, Tani M, et al. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: the differential diagnosis from benign entities. Arch Surg. 2004;139:188-192.
29. Vullierme MP, Giraud-Cohen M, Hammel P, et al. Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability. Radiology. 2007;245:483-490.
30. Nakagohri T, Kinoshita T, KonishiM, et al. Inferior head resection of the pancreas for noninvasive intraductal papillary mucinous adenocarcinoma. Hepatogastroenterology. 2004;51:256-258.
31. Couvelard A, Sauvanet A, Kianmanesh R, et al. Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation. Ann Surg. 2005;242:774-778, discussion 778-780.
32. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977-987.
33. Takahashi H, Nakamori S, Nakahira S, et al. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas. Ann Surg Oncol. 2006;13:955-960.
34. Nara S, Shimada K, Kosuge T, et al. Minimally invasive intraductal papillarymucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2008;32:243-255.
35. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
36. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8-13.
37. Standards of medical care in diabetes-2008. Diabetes Care. 2008;31(suppl 1):S12-S54.
38. Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007;133:72-79; quiz 309-310.
39. Chari ST, YadavD, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123:1500-1507.
40. Mino-Kenudson M, Fernandez-del Castillo C, Baba Y, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. 2011;60:1712-1720.
41. Turrini O, Schmidt CM, Pitt HA, et al. Side-branch intraductal papillary mucinous neoplasms of the pancreatic head/uncinate: resection or enucleation? HPB (Oxford). 2011;13:126-131.
42. Crippa S, Bassi C, Salvia R, et al. Enucleation of pancreatic neoplasms. Br J Surg. 2007;94:1254-1259.
43. Khashab MA, Kim K, Lennon AM, et al. Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms. Pancreas. 2013;42:717-721.
44. Falconi M, Salvia R, Bassi C, et al. Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg. 2001;88:376-381.
45. Salvia R, Malleo G, Marchegiani G, et al. Pancreatic resections for cystic neoplasms: from the surgeon's presumption to the pathologist's reality. Surgery. 2012;152(suppl 1):S135-S142.
46. Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007;102:1759-1764.
47. Shirakawa S, Matsumoto I, Toyama H, et al. Pancreatic volumetric assessment as a predictor of new-onset diabetes following distal pancreatectomy. J Gastrointest Surg. 2012;16:2212-2219.
48. He J, Cameron JL, Ahuja N, et al. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg. 2013;216:657-665; discussion 665-667.
49. White R, D'Angelica M, Katabi N, et al. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg. 2007;204:987-993; discussion 993-995.
50. Miller JR, Meyer JE, Waters JA, et al. Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm. HPB (Oxford). 2011;13:759-766.
51. Barbier L, Jamal W, Dokmak S, et al. Impact of total pancreatectomy: shortand long-term assessment [published online ahead of print January 29, 2013]. HPB (Oxford). doi:10.1111/hpb.12054.
52. Iacono C, Verlato G, Ruzzenente A, et al. Systematic review of central pancreatectomy and meta-analysis of central versus distal pancreatectomy. Br J Surg. 2013;100:873-885.
53. Hackert T, Hinz U, Fritz S, et al. Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections. Langenbecks Arch Surg. 2011;396:197-203.
54. Gurusamy KS, Koti R, Fusai G, et al. Somatostatin analogues for pancreatic surgery. Cochrane Database Syst Rev. 2013;4:CD008370.
55. Cauley CE, Pitt HA, Ziegler KM, et al. Pancreatic enucleation: improved outcomes compared to resection. J Gastrointest Surg. 2012;16:1347-1353.
56. Parikh P, Shiloach M, Cohen ME, et al. Pancreatectomy risk calculator: an ACS-NSQIP resource. HPB (Oxford). 2010;12:488-497.
57. Sugiyama M, Abe N, Tokuhara M, et al. Magnetic resonance cholangiopancreatography for postoperative follow-up of intraductal papillary-mucinous tumors of the pancreas. Am J Surg. 2003;185:251-255.
58. Jang JW, Kim MH, Jeong SU, et al. Clinical characteristics of intraductal papillary mucinous neoplasm manifesting as acute pancreatitis or acute recurrent pancreatitis. J Gastroenterol Hepatol. 2013;28:731-738.
59. Pelletier AL, Hammel P, Rebours V, et al. Acute pancreatitis in patients operated on for intraductal papillary mucinous neoplasms of the pancreas: frequency, severity, and clinicopathologic correlations. Pancreas. 2010;39:658-661.